Drug Side Effects
Search
LYMPHODEPLETION
LYMPHODEPLETION
was reported 34 times
LYMPHODEPLETION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-6 Antagonist [EPC]
1
0.0015
1
Chemokine Receptor Type 4 Interaction [EPC]
2
0.0015
2
CD38-directed Cytolytic Antibody [EPC]
7
0.0012
3
Lymphocyte Growth Factor [EPC]
1
0.0008
4
CD19-directed Chimeric Antigen Receptor [EPC]
2
0.0002
5
CD52-directed Cytolytic Antibody [EPC]
2
0.0001
6
Proteasome Inhibitor [EPC]
10
0.0001
7
B Lymphocyte Stimulator-specific Inhibitor [EPC]
2
0.0001
8
Interleukin-1 Receptor Antagonist [EPC]
1
0.0001
9
Human Immunoglobulin G [EPC]
1
0.0000
10
CD20-directed Cytolytic Antibody [EPC]
8
0.0000
11
Alkylating Drug [EPC]
6
0.0000
12
Thalidomide Analog [EPC]
11
0.0000
13
Calcineurin Inhibitor Immunosuppressant [EPC]
2
0.0000
14
Interleukin-6 Receptor Antagonist [EPC]
2
0.0000
15
Topoisomerase Inhibitor [EPC]
1
0.0000
16
Janus Kinase Inhibitor [EPC]
2
0.0000
17
gamma-Aminobutyric Acid-ergic Agonist [EPC]
1
0.0000
18
Corticosteroid [EPC]
14
0.0000
19
Kinase Inhibitor [EPC]
4
0.0000
20
Leukocyte Growth Factor [EPC]
1
0.0000
21
Platinum-based Drug [EPC]
1
0.0000
22
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
23
Platelet Aggregation Inhibitor [EPC]
1
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000